PrecisionSphere

Advertisement

cGxPJobs Banner

Lupin Debuts CGT-Exclusive Risperidone LAI in U.S. Market

Dateline: November 14, 2025 — Mumbai, India / Baltimore, MarylandLupin has launched its Risperidone Long-Acting Injectable (LAI) in the...

By cGxPwire Editor
November 16, 2025

Read More

Advertisement

cGxPJobs

Directory